Prediction of progression of atherosclerosis in patients with type 2 diabetes mellitus and chronic pancreatitis
| dc.contributor.author | Zhuravlyova, Larysa | |
| dc.contributor.author | Pylov, Daniel | |
| dc.contributor.author | Smirnov, Ivan | |
| dc.contributor.author | Radzishevska, Yevheniia | |
| dc.date.accessioned | 2021-06-12T16:00:15Z | |
| dc.date.available | 2021-06-12T16:00:15Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Due to a modern approach to treatment of type 2 diabetes mellitus (DM-2), it is easier to achieve disease compensation nowadays. However, even when blood glucose level is under control, risk of cardiovascular events (CVE) remains in individuals with DM. One of the reasons for occurrence of CVE is the presence of comorbid diseases in DM-2 and a number of other factors, namely: impaired lipid metabolism, inflammatory process, irregular blood glucose level control, which leads to increased time of blood glucose level being beyond the target range. Chronic pancreatitis (CP) is one of the most common comorbid diseases in DM-2. | en_US |
| dc.identifier.citation | Prediction of progression of atherosclerosis in patients with type 2 diabetes mellitus and chronic pancreatitis / D. Pylov, L. Zhuravlyova, I. Smirnov, E. Radzishevskaya // EUREKA: Health Sciences. – 2021. – N 1. – P. 24–32. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/28868 | |
| dc.language.iso | en | en_US |
| dc.subject | type 2 diabetes mellitus | en_US |
| dc.subject | atherosclerosis | en_US |
| dc.subject | carotid intima media thickness | en_US |
| dc.subject | vaspin | en_US |
| dc.subject | adipocytokines | en_US |
| dc.title | Prediction of progression of atherosclerosis in patients with type 2 diabetes mellitus and chronic pancreatitis | en_US |
| dc.type | Article | en_US |